Latest News Releases

Epistem Wins UK Trade and Investment Award

Epistem received the UKTI's 'Internationalise Your Business' award at the recent Genesis 2009 biotechnology conference in London. UKTI presents this award to the company which it judges has been most successful in expanding into new markets. Nominee companies are established companies who have extended their footprint with UKTI assistance, notably through the UKTI Tradeshow Access Programme. Epistem, led by Matthew Walls CEO,  is extremely pleased to have been honoured with this award which reflects the rapid recent expansion of its business, working with larger pharmaceutical companies in new overseas markets building on the successful presence which it has achieved in the UK.

10/12/2009